Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ILMN, HRMY, GERN, MRUS, ZLAB, and represent 41.52% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 10 stocks: ZLAB, SLNO, ELYM, REPL, MDGL, Bolt Projs Hldgs, LBPH, BCYC, ARGX, RARE.
- Started 5 new stock positions in SLNO, ELYM, ARGX, Bolt Projs Hldgs, RARE.
- Reduced shares in these 10 stocks: KALV, ATHA, , CABA, ROIV, GRAL, IMCR, IMTX, BMEA, ABCL.
- Sold out of its positions in ABCL, ATHA, BMEA, CABA, FGEN, GRAL, IMCR, KOD, PACB, ROIV. IMTX.
- Nan Fung Group Holdings was a net buyer of stock by $10M.
- Nan Fung Group Holdings has $116M in assets under management (AUM), dropping by 23.84%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 38 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Illumina (ILMN) | 13.4 | $16M | 119k | 130.41 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 12.7 | $15M | 369k | 40.00 |
|
|
| Geron Corporation (GERN) | 5.4 | $6.2M | 1.4M | 4.54 |
|
|
| Merus N V (MRUS) | 5.2 | $6.0M | 120k | 49.96 |
|
|
| Zai Lab Adr (ZLAB) | 4.9 | $5.7M | +327% | 235k | 24.14 |
|
| Longboard Pharmaceuticals In (LBPH) | 4.6 | $5.4M | +11% | 161k | 33.33 |
|
| Oculis Holding Ordinary Shares (OCS) | 4.6 | $5.3M | 436k | 12.26 |
|
|
| Beigene Sponsored Adr (BGNE) | 4.5 | $5.2M | 23k | 224.51 |
|
|
| Incyte Corporation (INCY) | 4.2 | $4.9M | 74k | 66.10 |
|
|
| Xenon Pharmaceuticals (XENE) | 3.6 | $4.2M | 107k | 39.37 |
|
|
| Exscientia Ads (EXAI) | 3.6 | $4.2M | 860k | 4.88 |
|
|
| Mirum Pharmaceuticals (MIRM) | 3.6 | $4.1M | 106k | 39.00 |
|
|
| Tourmaline Bio (TRML) | 3.3 | $3.8M | 147k | 25.71 |
|
|
| D Fluidigm Corp Del (LAB) | 3.1 | $3.6M | 1.9M | 1.93 |
|
|
| Soleno Therapeutics (SLNO) | 2.8 | $3.2M | NEW | 64k | 50.49 |
|
| Replimune Group (REPL) | 2.7 | $3.2M | +40% | 288k | 10.96 |
|
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $2.6M | 49k | 52.39 |
|
|
| Eliem Therapeutics (ELYM) | 2.0 | $2.4M | NEW | 464k | 5.09 |
|
| Madrigal Pharmaceuticals (MDGL) | 1.8 | $2.1M | +71% | 9.8k | 212.22 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $2.0M | 14k | 149.31 |
|
|
| Kalvista Pharmaceuticals (KALV) | 1.5 | $1.8M | -29% | 155k | 11.58 |
|
| Exelixis (EXEL) | 1.4 | $1.7M | 64k | 25.95 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $1.6M | 103k | 15.38 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.9 | $1.1M | 494k | 2.16 |
|
|
| Entrada Therapeutics (TRDA) | 0.7 | $784k | 49k | 15.98 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.7 | $760k | 11k | 70.29 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.7 | $756k | 1.2M | 0.65 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $715k | +82% | 32k | 22.63 |
|
| Bolt Projs Hldgs | 0.6 | $666k | NEW | 812k | 0.82 |
|
| Kymera Therapeutics (KYMR) | 0.4 | $515k | 11k | 47.33 |
|
|
| Revolution Medicines (RVMD) | 0.3 | $331k | 7.3k | 45.35 |
|
|
| Springworks Therapeutics (SWTX) | 0.2 | $239k | 7.5k | 32.04 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $233k | NEW | 430.00 | 542.08 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $212k | NEW | 3.8k | 55.55 |
|
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.1 | $130k | 186k | 0.70 |
|
|
| Affimed N V Ordinary Shs New (AFMD) | 0.1 | $125k | 37k | 3.36 |
|
|
| Aerovate Therapeutics (AVTE) | 0.1 | $100k | 48k | 2.09 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.1 | $76k | 42k | 1.82 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022
- Nan Fung Group Holdings 2021 Q4 filed Feb. 14, 2022
- Nan Fung Group Holdings 2021 Q3 filed Nov. 15, 2021
- Nan Fung Group Holdings 2021 Q2 filed Sept. 22, 2021